Table 6.
Meta-analysis results of Laboratory-related AEs - Subgroup analysis.
| Outcomes | Interventions in the control group | Studies | Participants | Heterogeneity test results | Effect model | Meta-analysis results | ||
|---|---|---|---|---|---|---|---|---|
| P | I2 | 95%CI | P | |||||
| Alanine aminotransferase increased | LEN+PD-1 | 2 | 240 | 0.02 | 81% | Random | 1.47 [0.48, 4.51] | 0.50 |
| LEN+TACE | 2 | 223 | 0.41 | 0% | 1.15 [0.68, 1.94] | 0.61 | ||
| Aspertate aminotransferase increased | LEN+PD-1 | 2 | 240 | 0.05 | 74% | Fixed | 1.12 [0.65, 1.92] | 0.68 |
| LEN+TACE | 2 | 223 | 0.78 | 0% | 1.65 [0.86, 3.17] | 0.13 | ||
| Albumin decreased | LEN+PD-1 | 2 | 240 | 0.39 | 0% | Fixed | 0.94 [0.47,1.88] | 0.86 |
| LEN | 2 | 157 | — | — | — | — | ||
TACE, transcatheter arterial chemoembolization; PD-1, programmeddeath-1; LEN, Lenvatinib. -, not available.